Chen et al. (2011) found that compared with well-differentiated CD133(+)/ALDH (high) or CD133(+)/EpCAM (+) cells, enhanced HH signaling activity in poorly differentiated HCC cells may be responsible for their chemical resistance and invasiveness. The gene discussed is EPCAM; the disease is hepatocellular carcinoma.